# Nemotron 3 Nano: Open, Efficient Mixture-of-Experts Hybrid Mamba-Transformer Model for Agentic Reasoning

Preprint · NVIDIA, :, Aaron Blakeman, Aaron Grattafiori, Aarti Basant, Abhibha Gupta, Abhinav Khattar, Adi Renduchintala, Aditya Vavre, Akanksha Shukla, Akhiad Bercovich, Aleksander Ficek, Aleksandr Shaposhnikov, Alex Kondratenko, Alexander Bukharin, Alexandre Milesi, Ali Taghibakhshi, Alisa Liu, Amelia Barton, Ameya Sunil Mahabaleshwarkar, Amir Klein, Amit Zuker, Amnon Geifman, Amy Shen, Anahita Bhiwandiwalla and 289 more

- Archive id: arxiv:2512.20848
- Published: 2025-12-23
- arXiv: https://arxiv.org/abs/2512.20848
- Citations: 0
- Source URL: https://arxiv.org/abs/2512.20848
- PDF: https://arxiv.org/pdf/2512.20848
- Provenance: arxiv

## Abstract

We present Nemotron 3 Nano 30B-A3B, a Mixture-of-Experts hybrid Mamba-Transformer language model. Nemotron 3 Nano was pretrained on 25 trillion text tokens, including more than 3 trillion new unique tokens over Nemotron 2, followed by supervised fine tuning and large-scale RL on diverse environments. Nemotron 3 Nano achieves better accuracy than our previous generation Nemotron 2 Nano while activating less than half of the parameters per forward pass. It achieves up to 3.3x higher inference throughput than similarly-sized open models like GPT-OSS-20B and Qwen3-30B-A3B-Thinking-2507, while also being more accurate on popular benchmarks. Nemotron 3 Nano demonstrates enhanced agentic, reasoning, and chat abilities and supports context lengths up to 1M tokens. We release both our pretrained Nemotron 3 Nano 30B-A3B Base and post-trained Nemotron 3 Nano 30B-A3B checkpoints on Hugging Face.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [LLM Architectures & Pretraining](https://space-kitty.com/topics/llm-architectures)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.